CN Stock MarketDetailed Quotes

Chengdu Olymvax Biopharmaceuticals Inc (688319)

Watchlist
  • 38.64
  • -0.86-2.18%
Market Closed May 14 15:00 CST
15.68BMarket Cap277.99P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc (688319) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
吸附破伤风疫苗613.66M87.15%
Group A C Meningococcal Polysaccharide binding Vaccine65.35M9.28%
Haemophilus influenzae type b combined vaccine18.76M2.66%
Other business4.03M0.57%
精制破伤风类毒素原液2.36M0.34%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry700.13M99.43%
Other business4.03M0.57%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China294.16M41.77%
Southwest123.87M17.59%
Central China107.35M15.24%
South China78.01M11.08%
North China51.75M7.35%
Northwest28.29M4.02%
Northeast China16.7M2.37%
Other business4.03M0.57%
Total special adjustments--
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More